跳至主要内容
临床试验/NCT06653361
NCT06653361已完成不适用

Ultra-Widefield Fluorescein Angiography-Based Targeted Retinal Photocoagulation Versus Conventional Panretinal Photocoagulation in the Preservation of Visual Function and Regression of Proliferative Diabetic Retinopathy

Hayatabad Medical Complex2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2022年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
120
试验地点
2
主要终点
CMT

研究概览

简要总结

Proliferative diabetic retinopathy is a vision-threatening disease that can lead to irreversible visual loss. The treatment options for proliferative diabetic retinopathy are anti-VEGF injection and retinal photocoagulation. The study aims to compare ultra-widefield fluorescein angiography-based targeted retinal photocoagulation and panretinal photocoagulation in the treatment of proliferative diabetic retinopathy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • proliferative diabetic retinopathy (PDR) with neovascularization on the disc or elsewhere in the retina

排除标准

  • Participants with a history of previous history of:
  • retinal photocoagulation
  • vitreoretinal surgery
  • tractional retinal detachment
  • epiretinal membrane
  • vitreomacular traction
  • media opacities like cataract, corneal opacity, vitreous hemorrhage
  • anti-VEGF injections in last 3 months

结局指标

主要结局

CMT

时间窗: 2 months

Central Macular Thickness

MD

时间窗: 2 months

Mean Deviation

VFI

时间窗: 2 months

Visual Filed Index

BCVA

时间窗: 2 months

Best Corrected Visual Acuity

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Yousaf Jamal Mahsood

Associate Professor

Hayatabad Medical Complex

研究点 (2)

Loading locations...

相似试验